Mpox Crisis Escalates in DR Congo as Antiviral Drug Fails

New strain prompts global health emergency; vaccine demand surges amid rising cases and mortality.

WHO declares mpox a global health emergency due to increased cases in the DRC and spread to neighboring countries.
Clinical trial reveals tecovirimat ineffective in reducing mpox lesion duration, highlighting need for alternative treatments.
Clade I mpox strain identified as more severe and transmissible, with children and immunocompromised individuals at higher risk.
Experts urge international vaccine rollout to combat the new strain, with calls for immediate action in the UK and Africa.
Hospitals in the DRC are overwhelmed as the virus spreads, with significant impacts on displaced and vulnerable populations.